New Drug for Dialysis-related Itching

Itching is a form of pain, and dialysis-related itching affects up to 40% of people on dialysis—with no approved treatment. Vifor Pharma and Cara Therapeutics have signed a licensing agreement to bring Korsuva (difelikefalin) injections to the market.

Read the full article » | Posted 11-12-2020

Related Articles

• Xeltis is Trialing its Polymer-based Vascular Access Posted 03-12-2026
• New Bluetooth-enabled CAPD System Enhanced Patient Satisfaction Posted 03-12-2026
• Emerging Biomarker Research in PD Posted 03-12-2026
• Byonyks’ X1 APD Cycler Received FDA 510(k) Approval Last Summer Posted 02-17-2026